Compassion S3 for Transcatheter Heart Valve Placement in Adults and Children - Clinical Trial
Email to Participate
melissa.harward@duke.edu
¿Cuál es el Propósito de este estudio?
We are doing this study to learn if SAPIEN 3 valve system is safe and will work with adults and children who have a dysfunctional right ventricular outflow tract (RVOT) conduit or have an implanted valve in the pulmonic position.
¿Cuál es la Condición que se está estudiando?
Dysfunctional pulmonary valve
¿Quién puede participar en el Estudio?
To be in this study, you must:
- Weigh at least 20 kg (about 44 pounds)
- Have a dysfunctional conduit or previously implanted valve
- Not have a current infection
- Not have any known blood clotting disorder
Grupo etario
Adultos, Niños
¿Qué Implica?
If you agree to be in the study, you will:
- Have the SAPIEN 3 Valve (study valve) implanted to your dysfunctional valve or conduit through cardiac catheterization
- Have 10 onsite visits over 5 years
- Have echocardiogram, exercise test, chest x-ray, and chest fluoroscopy during the study
Detalles del Estudio
Título Completo
COMPASSION S3: COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV (former Duke IRB title: Implantation of the SAPIEN 3 Transcatheter Heart Valve (THV) In the Pulmonic Position)
Investigador Principal
Gregory A. Fleming, MD, MSCI
Especialista en cardiología pediátrica
Número de Protocolo
IRB:
PRO00070466
NCT:
NCT02744677
Fase
Fase N/A
ClinicalTrials.gov
Ver en ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Participate
Email melissa.harward@duke.edu